BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 9144894)

  • 1. Stromal inhibition of epithelial cell growth in the prostate; overview of an experimental study.
    Kooistra A; Romijn JC; Schröder FH
    Urol Res; 1997; 25 Suppl 2():S97-105. PubMed ID: 9144894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stromal inhibition of prostatic epithelial cell proliferation not mediated by transforming growth factor beta.
    Kooistra A; van den Eijnden-van Raaij AJ; Klaij IA; Romijn JC; Schröder FH
    Br J Cancer; 1995 Aug; 72(2):427-34. PubMed ID: 7543773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative control of epithelial cell proliferation by prostatic stroma.
    Kooistra A; König JJ; Romijn JC; Schröder FH
    Anticancer Res; 1991; 11(4):1495-500. PubMed ID: 1720936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of prostatic epithelial cell proliferation by a factor secreted specifically by prostatic stromal cells.
    Kooistra A; König JJ; Keizer DM; Romijn JC; Schröder FH
    Prostate; 1995 Mar; 26(3):123-32. PubMed ID: 7899150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.
    Rowley DR; Dang TD; McBride L; Gerdes MJ; Lu B; Larsen M
    Cancer Res; 1995 Feb; 55(4):781-6. PubMed ID: 7850789
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor beta 1 (TGF beta 1), -beta 2, and- beta 3 by cultured human prostate cells.
    Story MT; Hopp KA; Molter M
    J Cell Physiol; 1996 Oct; 169(1):97-107. PubMed ID: 8841426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of prostatic basal cells in the regulation and suppression of human prostate cancer cells.
    Miniati DN; Chang Y; Shu WP; Peehl DM; Liu BC
    Cancer Lett; 1996 Jul; 104(2):137-44. PubMed ID: 8665481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen and prostatic stroma.
    Niu YJ; Ma TX; Zhang J; Xu Y; Han RF; Sun G
    Asian J Androl; 2003 Mar; 5(1):19-26. PubMed ID: 12646998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of matrix metalloproteinase-2 and -9 and their inhibitors, tissue inhibitor of metalloproteinase-1 and -2, in primary cultures of human prostatic stromal and epithelial cells.
    Wilson MJ; Sellers RG; Wiehr C; Melamud O; Pei D; Peehl DM
    J Cell Physiol; 2002 May; 191(2):208-16. PubMed ID: 12064464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proliferation and differentiation of prostatic stromal cells.
    Niu Y; Xu Y; Zhang J; Bai J; Yang H; Ma T
    BJU Int; 2001 Mar; 87(4):386-93. PubMed ID: 11251536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A human prostatic stromal myofibroblast cell line WPMY-1: a model for stromal-epithelial interactions in prostatic neoplasia.
    Webber MM; Trakul N; Thraves PS; Bello-DeOcampo D; Chu WW; Storto PD; Huard TK; Rhim JS; Williams DE
    Carcinogenesis; 1999 Jul; 20(7):1185-92. PubMed ID: 10383888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6.
    Degeorges A; Tatoud R; Fauvel-Lafeve F; Podgorniak MP; Millot G; de Cremoux P; Calvo F
    Int J Cancer; 1996 Oct; 68(2):207-14. PubMed ID: 8900430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatocyte growth factor secreted by prostate-derived stromal cells stimulates growth of androgen-independent human prostatic carcinoma cells.
    Nakashiro K; Okamoto M; Hayashi Y; Oyasu R
    Am J Pathol; 2000 Sep; 157(3):795-803. PubMed ID: 10980119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of phenotype of human prostatic stromal cells by transforming growth factor-betas.
    Hisataki T; Itoh N; Suzuki K; Takahashi A; Masumori N; Tohse N; Ohmori Y; Yamada S; Tsukamoto T
    Prostate; 2004 Feb; 58(2):174-82. PubMed ID: 14716743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide growth factors in the prostate as mediators of stromal epithelial interaction.
    Byrne RL; Leung H; Neal DE
    Br J Urol; 1996 May; 77(5):627-33. PubMed ID: 8689101
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta induces growth inhibition and IGF-binding protein-3 production in prostatic stromal cells: abnormalities in cells cultured from benign prostatic hyperplasia tissues.
    Cohen P; Nunn SE; Peehl DM
    J Endocrinol; 2000 Feb; 164(2):215-23. PubMed ID: 10657857
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of TGF-beta 1, TGF-alpha, and EGF on cell proliferation and cell death in rat ventral prostatic epithelial cells in culture.
    Ilio KY; Sensibar JA; Lee C
    J Androl; 1995; 16(6):482-90. PubMed ID: 8867596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of transforming growth factor-beta1 on parathyroid hormone-related protein mRNA expression and protein secretion in canine prostate epithelial, stromal, and carcinoma cells.
    Sellers RS; LeRoy BE; Blomme EA; Tannehill-Gregg S; Corn S; Rosol TJ
    Prostate; 2004 Mar; 58(4):366-73. PubMed ID: 14968437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects and characterization of paracrine factors produced by human prostate stromal cells in bioassays using rat Sertoli cells, LNCaP tumor cells, and cultured prostate epithelial cells.
    Goossens K; Deboel L; Swinnen JV; De Gendt K; Rombauts W; Verhoeven G
    Prostate; 2001 Jul; 48(2):104-17. PubMed ID: 11433420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cathepsin D acts as an essential mediator to promote malignancy of benign prostatic epithelium.
    Pruitt FL; He Y; Franco OE; Jiang M; Cates JM; Hayward SW
    Prostate; 2013 Apr; 73(5):476-88. PubMed ID: 22996917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.